A deal has been reached between the US and UK to eliminate tariffs on pharmaceuticals, with the UK reportedly gaining tariff-free access to the US market for its medicines. However, the agreement has sparked concerns among some groups, who claim it could lead to increased costs for the UK's National Health Service and potentially harm public health. The exact implications of the deal are unclear, with some outlets suggesting it could have significant financial and human costs.